5-(arylsulfonyl)-pyrazolopiperidines

Details for Australian Patent Application No. 2006320423 (hide)

Owner Elan Pharmaceuticals, Inc.

Inventors Konradi, Andrei W.; Xu, Ying-Zi; Semko, Christopher M.; Jagodzinski, Jacek J.; Ye, Xiaocong Michael; Smith, Jenifer L.; Garofalo, Albert W.

Agent Freehills

Pub. Number AU-B-2006320423

PCT Pub. Number WO2007/064914

Priority 60/741,366 01.12.05 US

Filing date 1 December 2006

Wipo publication date 7 June 2007

Acceptance publication date 21 June 2012

International Classifications

C07D 211/96 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/04 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/064914 Priority application(s): WO2007/064914

21 June 2012 Application Accepted

  Published as AU-B-2006320423

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006320425-Fitting a neural prosthesis using impedance and electrode height

2006320418-Advanced capillary force vaporizers